Glycosylated Hemoglobin (HbA1c) as a Predictor of Adverse Outcomes in Left Ventricular Assist Device (LVAD) Patients

E. Einarson, A. Eisenbeiss, J. Nelson, K. Graham,R. Alharethi,W.T. Caine,H. Smith,B.B. Reid,M. McCulloch,B. Rasmusson,V. Hebl,A.G. Kfoury

JOURNAL OF HEART AND LUNG TRANSPLANTATION（2018）

引用 0|浏览29

暂无评分

摘要

Elevated HbA1c levels have been associated with adverse outcomes in the general heart failure population. It is unclear whether this association also exists in patients who have undergone LVAD implantation. This study sought to determine if HbA1c is a reliable predictor of adverse outcomes in LVAD patients.

查看译文

关键词

glycosylated hemoglobin,left ventricular assist device,hba1c,lvad

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要